| Literature DB >> 35275082 |
Julia Keizer1, Britt E Bente1, Nashwan Al Naiemi2,3, Lisette Jewc Van Gemert-Pijnen1, Nienke Beerlage-De Jong4.
Abstract
BACKGROUND: For eHealth technologies in general and audit and feedback (AF) systems specifically, integrating interdisciplinary theoretical underpinnings is essential, as it increases the likelihood of achieving desired outcomes by ensuring a fit among eHealth technology, stakeholders, and their context. In addition, reporting on the development and implementation process of AF systems, including substantiations of choices, enables the identification of best practices and accumulation of knowledge across studies but is often not elaborated on in publications.Entities:
Keywords: antibiotic stewardship; antimicrobial resistance; audit and feedback; development; eHealth; implementation; infection control; scoping review
Mesh:
Substances:
Year: 2022 PMID: 35275082 PMCID: PMC8957011 DOI: 10.2196/33531
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 7.076
Figure 1PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flowchart of included and excluded studies, including reasons for exclusion.
Study characteristics.
| Author and country | Journal | Study aims | Study targets | Target group | Study design and methods | Theoretical underpinning |
| Boscart et al, Canada [ | Implementation science | To identify nurses’ and administrators’ perceived barriers and facilitators to current HHa practices and the implementation of a new electronic monitoring technology for HH | ICPb and HAIc: HH (improving HH compliance) | Nurses and administrators | Qualitative: Semistructured key informant interviews | Theoretical Domains Framework |
| Conway et al, United States [ | The Joint Commission Journal on Quality and Patient Safety | To describe the implementation of an automated group monitoring and feedback system for promoting HH among HCWsd and report its impact on the frequency of HH at a community hospital | ICP and HAI: HH (increase HH frequency) | HCWs (eg, nurses and respiratory therapists), administrators, and managers | Multiple methods: Quantitative: before-and-after study on HH events per patient hour (outcome) Qualitative: focus groups | Model of Actionable Feedback |
| Edmisten et al, United States [ | American Journal of Infection Control | To describe the implementation of an electronic HH monitoring system in 3 community hospitals, including the challenges and drivers of success and the maintenance activities needed for continued improvements in compliance with HH practices | ICP and HAI: HH (improving HH compliance) | HCWs, staff, unit/department directors and, facility management | Multiple methods: Quantitative: after study (outcome measures on HH compliance after implementation) Qualitative: direct input from users/department and facility leaders, direct observation, and analysis of system-generated data and sharing of best practices between facilities | None reported |
| Hysong et al, United States [ | BMJ Quality and Safety | To describe how feedback intervention theory can be systematically applied in health care settings to design better feedback interventions | DSPe and HAI: to improve internal-medicine resident’s and long-term care personnel’s capacity to distinguish between asymptomatic bacteriuria and catheter-associated urinary tract infection | HCWs (eg, nurse practitioners and staff physicians) | Multiple methods: Quantitative: the Smither et al [ Quantitative: chart monitoring (adherence to the treatment algorithm, specifically, rates of urine culture) of orders and inappropriate use of antibiotics | Feedback Intervention Theory |
| James, Australia [ | The Journal of Antimicrobial Chemotherapy | To design an audit tool that was appropriate for use in all Australian hospitals, suited to local user requirements, and included an assessment of the overall appropriateness of the prescription | ASPf: to improve the quality of patient care by reducing inappropriate and unnecessary use of antimicrobials (national level focus) | HCWs (eg, pharmacists and nurses) | Multiple methods: Quantitative: interrater reliability and validity tests and web-based questionnaire Qualitative: teleconference and direct input from users | None reported |
| Jeanes et al, United Kingdom [ | American Journal of Infection Control | To develop and implement an infection control performance and quality improvement data collection tool to meet the needs of large, acute health care providers and improve the credibility and use of infection control performance monitoring | ICP and HAI: to improve the credibility and use of infection control performance monitoring (beyond HH) | Not clearly described; (“auditors” and managers) | Multiple methods: Quantitative: questionnaires and intermittent validation Qualitative: day to day contacts with auditors, feedback from users via the IC-CQIg data input system, discussion groups, and IC-CQI training sessions | Pronovost Knowledge Translation Cycle and Barriers and Mitigation tool, double loop learning cycle, and Hexagon tool framework |
| Keizer, the Netherlands [ | Lecture Notes in Computer Science | To describe how a bottom-up participatory development approach can improve the persuasive design of data-driven technologies for their end user (ie, HCWs) and within their context and describe how bottom-up participatory development is a necessary precondition for the development of persuasive data-driven technologies that foster sustainable implementation | DSP, ASP, and ICP: to optimize HCWs’ diagnostic, antibiotic prescription and infection control behavior to limit AMRh | HCWs (eg, urologists and residents) | Multiple methods: Quantitative: questionnaire Qualitative: 2 focus groups (last focus group prototype based) | CeHResi road map |
| Marques, Portugal [ | BMC Medical Informatics and Decision Making | To develop a gamification solution that can provide HCWs real-time feedback on personal HH compliance | ICP and HAI: to create awareness regarding HCWs’ HH compliance while trying to change their behaviors and optimize their performance | Nurses | Multiple methods (2 work iterations): Qualitative: preliminary experiments, simulations, field studies, and focus groups | Design Science Research Methodology and gamification |
| Pakyz, United States [ | American Journal of Infection Control | To identify the factors related to the implementation of ASP strategies | ASP: to optimize the use of antimicrobial agents, decrease AMR, and decrease rates of | ASP pharmacists and physicians | Multiple methods: Quantitative: survey Qualitative: semistructured telephone interviews | None reported |
| Parker, Australia [ | Journal of Clinical Nursing | To provide insights into the experiences of clinicians in implementing a multifaceted bundled urinary catheter care intervention (of which AFj is a considerable component) | HAI: the study aimed to reduce catheter use and duration of catheterization | Clinicians (eg, nurses and resident medical officers) | Qualitative: Postimplementation focus groups | Intervention Description and Replication framework |
| Patel, United States [ | Interdisciplinary Perspectives on Infectious Diseases | To describe the development and implementation of their AF intervention using a theoretical framework | ASP: to promote the judicious use of antibiotics | HCWs (eg, neonatologists and pediatric residents) | Multiple methods: Quantitative: retrospective observational study of antibiotic use and clinical vignette study Qualitative: ethnographic workflow study and 2 focus groups | Model of Actionable Feedback |
| Power, United Kingdom [ | International Journal for Quality in Health Care | To set up a low-cost pragmatic system to provide monthly data on 4 harms across care settings and produce measures that could be used locally for improvement but also aggregated to determine the burden of harm nationally | HAI: to reduce 4 high volume harms (safety outcomes), pressure ulcers, falls, urinary tract infection in patients with catheters, and venous thromboembolism | HCWs (eg, nurses and junior physicians) | Multiple methods: Quantitative: questionnaire survey (professional satisfaction) Qualitative: paper-based prototyping, formative evaluation by interaction with testers, web forum (including mail queries), regional leads, face-to-face meetings, and regional measurement workshops | ProjectPplan Framework and Plan, Do, Study, Act Method |
aHH: hand hygiene.
bICP: infection control program.
cHAI: hospital-acquired infection.
dHCW: health care worker.
eDSP: diagnostic stewardship program.
fASP: antimicrobial stewardship program.
gIC-CQI: Infection Control Continuous Quality Improvement.
hAMR: antimicrobial resistance.
iCeHRes: Center for eHealth Research.
jAF: audit and feedback.
Conceptual framework: APM-AFa system constructs (N=12)b.
| Constructs and subconstructs | Audit and feedbackc | eHealth and interventionsd | Implementatione | Studies, n (%) | |||||||||||||||||||||
|
| [ | [ | [ | [ | [ | [ | [ | [ | [ |
| |||||||||||||||
|
| |||||||||||||||||||||||||
|
| Auditeesf |
|
|
|
| ✓ |
|
| ✓ |
| 10 (83) | ||||||||||||||
|
| Main |
|
|
|
|
| ✓ |
|
|
| 9 (75) | ||||||||||||||
|
| |||||||||||||||||||||||||
|
| Feedback recipientsf |
|
|
|
| ✓ |
| ✓ | ✓ |
| 8 (67) | ||||||||||||||
|
| Main | ✓ |
|
|
|
| ✓ | ✓ |
|
| 8 (67) | ||||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Feedback provided to individual, groups, or bothf | ✓ |
| ✓ |
| ✓ | ✓ |
|
|
| 11 (92) | |||||||||||||
|
|
| Feedback is about the individual or team’s own behaviorsb | ✓ | ✓ | ✓ | ✓ |
|
|
|
|
| 10 (83) | |||||||||||||
|
|
| Feedback level specificityf | ✓ |
| ✓ | ✓ |
| ✓ |
|
|
| 8 (67) | |||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Comparisonf | ✓ | ✓ |
| ✓ |
| ✓ | ✓ |
|
| 8 (67) | |||||||||||||
|
|
| Goal settingg | ✓ | ✓ |
| ✓ |
|
| ✓ | ✓ |
| 5 (42) | |||||||||||||
|
|
| Action planningg | ✓ | ✓ |
| ✓ |
| ✓ | ✓ | ✓ |
| 4 (33) | |||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Punitivenessb |
|
| ✓ | ✓ |
|
|
|
|
| 6 (50) | |||||||||||||
|
|
| Attack on self-identityf |
|
|
| ✓ |
|
|
|
| ✓ | 4 (33) | |||||||||||||
|
|
| Intrinsic and extrinsic reinforcement or incentivesf |
|
|
| ✓ |
|
|
| ✓ |
| 4 (33) | |||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Delivery timingf | ✓ | ✓ |
| ✓ |
| ✓ |
|
|
| 8 (67) | |||||||||||||
|
|
| Timeliness (frequency and continuous cycle)f | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
|
| 11 (92) | |||||||||||||
|
|
| Remindersf |
|
|
| ✓ |
| ✓ |
|
|
| 3 (25) | |||||||||||||
|
| |||||||||||||||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Key features of the technologyf |
|
|
|
|
| ✓ | ✓ |
| ✓ | 11 (92) | |||||||||||||
|
|
| Accessb |
|
|
|
|
| ✓ |
|
|
| 12 (100) | |||||||||||||
|
|
| Materialsb |
|
|
|
| ✓ | ✓ | ✓ |
|
| 8 (67) | |||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Modes of feedback deliveryf | ✓ | ✓ |
| ✓ | ✓ | ✓ | ✓ |
|
| 9 (75) | |||||||||||||
|
|
| Level of human involvementf |
|
|
|
|
| ✓ |
|
| ✓ | 9 (75) | |||||||||||||
|
|
| Engagementb |
|
|
| ✓ |
|
|
|
|
| 6 (50) | |||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Visual presentation strategies and cognitive loadg | ✓ | ✓ | ✓ |
|
|
| ✓ | ✓ |
| 9 (75) | |||||||||||||
|
|
| User-guided experienceg | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 4 (33) | |||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Data validityb |
| ✓ |
| ✓ |
|
|
|
|
| 9 (75) | |||||||||||||
|
|
| Trust and credibilityf |
| ✓ |
| ✓ |
|
|
| ✓ |
| 11 (92) | |||||||||||||
|
| |||||||||||||||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Reflective learningf | ✓ |
|
| ✓ |
|
|
| ✓ |
| 5 (42) | |||||||||||||
|
|
| Learning climatef |
|
|
| ✓ |
|
|
| ✓ |
| 7 (58) | |||||||||||||
|
| Additional strategies or proceduresb |
|
|
|
| ✓ | ✓ | ✓ |
|
| 12 (100) | ||||||||||||||
aAPM-AF: audit and feedback for antimicrobial resistance prevention measures.
bUnique constructs (ie, where the various perspectives complement each other).
cApproximately 72% of constructs theoretically underpinned by literature on audit and feedback.
dApproximately 66% of constructs theoretically underpinned by literature on eHealth and interventions.
eApproximately 41% of constructs theoretically underpinned by literature on implementation.
fOverlapping constructs (constructs represented in 2 perspectives).
gOverlapping constructs (constructs represented in all perspectives).
Conceptual framework: APM-AFa development and implementation constructs (N=12)b.
| Constructs and subconstructs | Audit and feedbackc | eHealth and interventionsd | Implementatione | Studies, n (%) | |||||||||||||||||||||
|
| [ | [ | [ | [ | [ | [ | [ | [ | [ |
| |||||||||||||||
|
| |||||||||||||||||||||||||
|
| Developer or research teamb |
|
|
|
| ✓ |
|
|
|
| 5 (42) | ||||||||||||||
|
| Pilot testers and involvement in development and implementation processf |
|
|
| ✓ | ✓ |
|
| ✓ |
| 11 (92) | ||||||||||||||
|
| Leadership engagementb |
|
|
|
|
|
|
| ✓ | ✓ | 6 (50) | ||||||||||||||
|
| Opinion leadersb |
|
|
|
|
|
|
| ✓ |
| 3 (25) | ||||||||||||||
|
| Formally appointed internal implementation leadersb |
|
|
|
|
|
|
| ✓ |
| 2 (17) | ||||||||||||||
|
| Championsb |
|
|
|
|
|
|
| ✓ |
| 3 (25) | ||||||||||||||
|
| |||||||||||||||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Nature of the problemb |
|
|
|
|
|
|
|
| ✓ | 12 (100) | |||||||||||||
|
|
| Description of underlying behavior and decision processesb | ✓ |
|
| ✓ |
|
|
|
|
| 12 (100) | |||||||||||||
|
|
| Relevant sociocultural factors and comorbiditiesg |
|
|
|
|
|
|
|
| ✓ | 8 (67) | |||||||||||||
|
|
| Perceived need for behavior changeg | ✓ |
|
|
|
|
|
| ✓ |
| 4 (33) | |||||||||||||
|
|
| Targeted behavior is likely to be amenable to feedbackb | ✓ | ✓ |
| ✓ |
|
|
|
|
| 6 (50) | |||||||||||||
|
|
| Self-efficacyg |
| ✓ |
| ✓ |
|
|
| ✓ |
| 3 (25) | |||||||||||||
|
|
| Justify need for behavior changeg | ✓ |
|
| ✓ |
|
|
|
| ✓ | 10 (83) | |||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Rationale for using APM-AFg | ✓ |
|
|
| ✓ | ✓ |
|
|
| 12 (100) | |||||||||||||
|
|
| Desirability, efficacy, safety, and cost effectivenessg |
|
|
| ✓ |
|
|
| ✓ | ✓ | 10 (83) | |||||||||||||
|
|
| Relative advantageb |
|
|
|
|
|
|
| ✓ |
| 10 (83) | |||||||||||||
|
| |||||||||||||||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Complexity of implementation processb |
|
|
|
|
|
|
| ✓ | ✓ | 8 (67) | |||||||||||||
|
|
| Technology supply modelb |
|
|
|
|
|
|
|
| ✓ | 8 (67) | |||||||||||||
|
|
| Compatibilityg |
|
|
| ✓ |
|
|
| ✓ | ✓ | 11 (92) | |||||||||||||
|
|
| Remove barriersg |
|
|
| ✓ |
| ✓ |
|
| ✓ | 11 (92) | |||||||||||||
|
|
| Opportunity costs (including additional efforts to use technology) g |
|
|
| ✓ |
|
|
| ✓ | ✓ | 3 (25) | |||||||||||||
|
|
| Available resourcesb |
|
|
|
|
|
|
| ✓ | ✓ | 6 (50) | |||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Structural characteristicsb |
|
|
|
|
|
|
| ✓ | ✓ | 1 (8) | |||||||||||||
|
|
| Networks and communicationsb |
|
|
|
|
|
|
| ✓ | ✓ | 2 (17) | |||||||||||||
|
|
| Cultureb |
|
|
|
|
|
|
| ✓ |
| 3 (25) | |||||||||||||
|
|
| Patient needs and resourcesb |
|
|
|
|
|
|
| ✓ |
| 1 (8) | |||||||||||||
|
|
| ||||||||||||||||||||||||
|
|
| Planningb |
|
|
|
|
|
|
| ✓ | ✓ | 6 (50) | |||||||||||||
|
|
| Executingb |
|
|
|
|
|
|
| ✓ | ✓ | 5 (42) | |||||||||||||
|
| |||||||||||||||||||||||||
|
| Intended useb |
|
|
|
| ✓ | ✓ |
|
|
| 1 (8) | ||||||||||||||
|
| Actual useb |
|
|
|
| ✓ |
|
|
|
| 3 (25) | ||||||||||||||
|
| Development process and formative evaluationsg |
|
|
|
|
| ✓ |
| ✓ |
| 12 (100) | ||||||||||||||
|
| Harms or unintended effectsb |
|
|
|
|
| ✓ |
|
|
| 4 (33) | ||||||||||||||
|
| Trialabilityb |
|
|
|
|
|
|
| ✓ |
| 9 (75) | ||||||||||||||
|
| Revisions and updatingg |
|
|
|
| ✓ |
|
| ✓ | ✓ | 6 (50) | ||||||||||||||
|
| Replicability and digital preservationb |
|
|
|
|
|
|
| ✓ |
| 1 (8) | ||||||||||||||
aAPM-AF: audit and feedback for antimicrobial resistance prevention measures.
bUnique constructs (ie, where the various perspectives complement each other).
cApproximately 32% of constructs theoretically underpinned by literature on audit and feedback.
dApproximately 24% of constructs theoretically underpinned by literature on eHealth and interventions.
eApproximately 74% of constructs theoretically underpinned by literature on implementation.
fOverlapping constructs (constructs represented in all perspectives).
gOverlapping constructs (constructs represented in 2 perspectives).
Constructs of APM-AFa systems (N=12).
| Constructs and subconstructs | Described by studies, n (%) | References | |||||||||
|
| Described elaborately and often substantiated | Partially described or constructed without elaboration or substantiation | Not described or substantiated |
| |||||||
|
| |||||||||||
|
| Auditees | 10 (83) | 1 (8) | 1 (8) | [ | ||||||
|
| Main input | 9 (75) | 3 (25) | 0 (0) | [ | ||||||
|
| |||||||||||
|
| Feedback recipients | 8 (67) | 3 (25) | 1 (8) | [ | ||||||
|
| Main output | 8 (67) | 3 (25) | 1 (8) | [ | ||||||
|
|
| ||||||||||
|
|
| Feedback provided to individual, groups, or both | 11 (92) | 1 (8) | 0 (0) | [ | |||||
|
|
| Feedback about the individual or team’s own behaviors | 10 (83) | 2 (17) | 0 (0) | [ | |||||
|
|
| Specificity | 8 (67) | 1 (8) | 3 (25) | [ | |||||
|
|
| ||||||||||
|
|
| Comparison | 8 (67) | 0 (0) | 4 (33) | [ | |||||
|
|
| Goal setting | 5 (42) | 1 (8) | 6 (50) | [ | |||||
|
|
| Action planning | 4 (33) | 3 (25) | 5 (42) | [ | |||||
|
|
| ||||||||||
|
|
| Punitiveness | 6 (50) | 0 (0) | 6 (50) | [ | |||||
|
|
| Attack on self-identity and cognitive influences | 4 (33) | 0 (0) | 8 (67) | [ | |||||
|
|
| Intrinsic and extrinsic reinforcement or incentives | 4 (33) | 0 (0) | 8 (67) | [ | |||||
|
|
| ||||||||||
|
|
| Delivery timing | 8 (67) | 0 (0) | 4 (33) | [ | |||||
|
|
| Timeliness | 11 (92) | 1 (8) | 0 (0) | [ | |||||
|
|
| Reminders | 3 (25) | 0 (0) | 9 (75) | [ | |||||
|
| |||||||||||
|
|
| ||||||||||
|
|
| Materials | 11 (92) | 1 (8) | 0 (0) | [ | |||||
|
|
| Key features of the technology | 12 (100) | 0 (0) | 0 (0) | [ | |||||
|
|
| Access | 8 (67) | 0 (0) | 4 (33) | [ | |||||
|
|
| ||||||||||
|
|
| Modes of feedback delivery | 9 (75) | 2 (17) | 1 (8) | [ | |||||
|
|
| Level of human involvement | 9 (75) | 3 (25) | 0 (0) | [ | |||||
|
|
| Engagement | 6 (50) | 0 (0) | 6 (50) | [ | |||||
|
|
| ||||||||||
|
|
| Presentation strategies and cognitive load | 9 (75) | 1 (8) | 2 (17) | [ | |||||
|
|
| User-guided experience | 4 (33) | 3 (25) | 5 (42) | [ | |||||
|
|
| ||||||||||
|
|
| Data validity | 9 (75) | 1 (8) | 2 (17) | [ | |||||
|
|
| Trust and credibility | 11 (92) | 0 (0) | 1 (8) | [ | |||||
|
| |||||||||||
|
|
| ||||||||||
|
|
| Reflective learning | 5 (42) | 0 (0) | 7 (58) | [ | |||||
|
|
| Learning climate | 7 (58) | 0 (0) | 5 (42) | [ | |||||
|
| Additional strategies or procedures | 12 (100) | 0 (0) | 0 (0) | [ | ||||||
aAPM-AF: audit and feedback for antimicrobial resistance prevention measures.
APM-AFa development and implementation constructs.
| Constructs and subconstructs | Described by studies, n (%) | References | |||||||||
|
| Described elaborately and often substantiated | Partially described or constructed without elaboration or substantiation | Not described or substantiated |
| |||||||
|
| |||||||||||
|
|
| ||||||||||
|
|
| Developer or research team | 5 (42) | 4 (33) | 3 (25) | [ | |||||
|
|
| Pilot testers and involvement in development and implementation process | 11 (92) | 2 (17) | 1 (8) | [ | |||||
|
|
| Leadership engagement | 6 (50) | 2 (17) | 4 (33) | [ | |||||
|
|
| Opinion leaders | 3 (25) | 0 (0) | 9 (75) | [ | |||||
|
|
| Formally appointed internal implementation leaders | 2 (17) | 0 (0) | 10 (83) | [ | |||||
|
|
| Champions | 3 (25) | 1 (8) | 8 (67) | [ | |||||
|
| |||||||||||
|
|
| ||||||||||
|
|
| Description of underlying behavior and decision processes | 8 (67) | 2 (17) | 2 (17) | [ | |||||
|
|
| Nature of the problem | 12 (100) | 0 (0) | 0 (0) | [ | |||||
|
|
| Relevant sociocultural factors and comorbidities | 12 (100) | 0 (0) | 0 (0) | [ | |||||
|
|
| Tension for behavior change | 4 (33) | 1 (8) | 7 (58) | [ | |||||
|
|
| Targeted behavior is likely to be amenable to feedback | 6 (50) | 0 (0) | 6 (50) | [ | |||||
|
|
| Self-efficacy | 3 (25) | 0 (0) | 9 (75) | [ | |||||
|
|
| Justify need for behavior change | 10 (83) | 0 (0) | 2 (17) | [ | |||||
|
|
| ||||||||||
|
|
| Rationale for using AFb | 12 (100) | 0 (0) | 0 (0) | [ | |||||
|
|
| Desirability, efficacy, safety, and cost-effectiveness | 10 (83) | 0 (0) | 2 (17) | [ | |||||
|
|
| Relative advantage | 10 (83) | 0 (0) | 2 (17) | [ | |||||
|
| |||||||||||
|
|
| ||||||||||
|
|
| Complexity of implementation process | 8 (67) | 1 (8) | 3 (25) | [ | |||||
|
|
| Technology supply model | 8 (67) | 0 (0) | 4 (33) | [ | |||||
|
|
| Compatibility | 11 (92) | 1 (8) | 0 (0) | [ | |||||
|
|
| Remove barriers | 11 (92) | 0 (0) | 1 (8) | [ | |||||
|
|
| Opportunity costs (including additional efforts to use technology) | 3 (25) | 1 (8) | 8 (67) | [ | |||||
|
|
| Available resources | 6 (50) | 2 (17) | 4 (33) | [ | |||||
|
|
| ||||||||||
|
|
| Structural characteristics | 1 (8) | 0 (0) | 11 (92) | [ | |||||
|
|
| Networks and communications | 2 (17) | 0 (0) | 10 (83) | [ | |||||
|
|
| Culture | 3 (25) | 3 (25) | 6 (50) | [ | |||||
|
|
| Patient needs and resources | 1 (8) | 1 (8) | 10 (83) | [ | |||||
|
|
| ||||||||||
|
|
| Planning | 6 (50) | 0 (0) | 6 (50) | [ | |||||
|
|
| Execution | 5 (42) | 0 (0) | 7 (58) | [ | |||||
|
| |||||||||||
|
|
| ||||||||||
|
|
| Intended use | 1 (8) | 1 (8) | 10 (83) | [ | |||||
|
|
| Actual use | 3 (25) | 2 (17) | 7 (58) | [ | |||||
|
| Development process and formative evaluations | 11 (92) | 1 (8) | 0 (0) | [ | ||||||
|
| Harms or unintended effects | 4 (33) | 0 (0) | 8 (67) | [ | ||||||
|
| Trialability | 9 (75) | 1 (8) | 2 (17) | [ | ||||||
|
| Revisions and updating | 6 (50) | 1 (8) | 5 (42) | [ | ||||||
|
| Replicability and digital preservation | 1 (8) | 1 (8) | 10 (83) | [ | ||||||
aAPM-AF: audit and feedback for antimicrobial resistance prevention measures.
bAF: audit and feedback.